GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: Hengqu® | SHR-8735
hetrombopag is an approved drug (China (2021))
Compound class:
Synthetic organic
Comment: Hetrombopag is an orally bioavailable, non-peptide small‐molecule thrombopoietin receptor (TPOR/MPL) agonist, that was developed as a treatment for thrombocytopenia [1]. The parent compound is shown here. It is administered as the ethanolamine/olamine.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes. China NMPA (2021) |
IUPAC Name ![]() |
| 5-[2-hydroxy-3-[[5-methyl-3-oxo-2-(5,6,7,8-tetrahydronaphthalen-2-yl)-1H-pyrazol-4-yl]diazenyl]phenyl]furan-2-carboxylic acid |
Synonyms ![]() |
| Hengqu® | SHR-8735 |
Database Links ![]() |
|
| CAS Registry No. | 1257792-41-8 |
| GtoPdb PubChem SID | 404859104 |
| PubChem CID | 135565610 |
| Search Google for chemical match using the InChIKey | YATJUTCKRWETAB-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | YATJUTCKRWETAB |
| UniChem Compound Search for chemical match using the InChIKey | YATJUTCKRWETAB-UHFFFAOYSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | YATJUTCKRWETAB-UHFFFAOYSA-N |